Prof. Dr. Marc Ferrante is assistant professor at KU Leuven (Leuven, Belgium) since 2013. Since 2012, Marc Ferrante is a staff member of the Department of Gastroenterology at the University Hospitals Leuven. He is a lecturer for the students of Biomedical Sciences and Medicine, and coach of the clinical fellows in training.
Marc Ferrante pursued his training in internal medicine and gastroenterology at the KU Leuven. He obtained his medical degree in 2002 and his Belgian board certification in gastroenterology in 2010. During his training he performed internships in Tygerberg (Stellenbosch, South-Africa), Chris Hani Baragwanath (Johannesburg, South-Africa) and Onze-Lieve-Vrouwziekenhuis (Aalst, Belgium).
In 2007, he successfully defended his PhD, which was entitled “Assessing and predicting disease progression in IBD: a clinical and molecular approach”. In 2010, Marc Ferrante initiated his post-doctoral work at the Hubrecht Institute in Utrecht, the Netherlands, under the supervision of Hans Clevers. With the knowledge gained in this renowned centre, Marc Ferrante started his own research group at the KU Leuven in close collaboration with Catherine Verfaillie from the Stem Cell Institute of Leuven and the IBD team. His group is currently focusing on the influence of microbiota on intestinal stem cell behaviour and differentiation in patients with IBD.
Marc Ferrante published more than 120 papers in high ranked gastroenterology journals (H index: 34). For his work he has received numerous research awards including the van Genechten-Paternoster en Prof G Vantrappen Award, the Willy and Marcy De Vooght Foundation Award, as well as an ECCO and CREA Research Grant. He was awarded as Rising Star in Gastroenterology at the European Congress of Gastroenterology in 2014.
Marc Ferrante holds a basic-clinical research position at the Flemish Foundation for Scientific Research (FWO Vlaanderen). He is board member and treasurer of the Belgian IBD Research and Development (BIRD) group, chair of the Clinical Committee of the European Crohn’s and Colitis Organization (ECCO), and previous chair of Young ECCO. He is member of the Editorial Board of the Journal of Crohn’s and Colitis, reviewer for many gastroenterology journals, and central reader for several multi-centre clinical trials.